Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Correction: Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-09-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/11/9/e006802corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interferon alpha-induced reduction in the values of myeloid-derived suppressor cells in melanoma patients
by: Stanojević Ivan, et al.
Published: (2015-01-01)

The gut microbiota protein BOC1 exhibits immune checkpoint inhibitor-like activity by inhibiting myeloid-derived suppressor cell differentiation
by: Laureen Bardouillet, et al.
Published: (2025-08-01)

Depletion of myeloid-derived suppressor cells sensitizes murine multiple myeloma to PD-1 checkpoint inhibitors
by: Qiang Wang, et al.
Published: (2025-01-01)

Pre-treatment monocytic myeloid-derived suppressor cells as predictive biomarkers for immune checkpoint inhibitor response in clear cell renal cell carcinoma
by: Yiming Jin, et al.
Published: (2025-08-01)

The Recruitment and Immune Suppression Mechanisms of Myeloid‐Derived Suppressor Cells and Their Impact on Bone Metastatic Cancer
by: Chengyuan Li, et al.
Published: (2025-02-01)

The role of myeloid-derived suppressor cells in children
by: Jordan Brauner, et al.
Published: (2025-02-01)

DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
by: Bastian Schilling, et al.
Published: (2021-07-01)

Decreased number of myeloid-derived suppressor cells in the placental trophoblast of gestational diabetes mellitus. Possible role of leptin
by: Malika Tami, et al.
Published: (2025-05-01)

Aging modulates the immunosuppressive, polarizing and metabolic functions of blood-derived myeloid-derived suppressor cells (MDSCs)
by: Emma Keltsch, et al.
Published: (2025-07-01)

Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer
by: Hiroshi Katoh, et al.
Published: (2015-01-01)

Myeloid-derived suppressor cells and their role in gynecological malignancies
by: Seiji Mabuchi, et al.
Published: (2018-08-01)

Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)

Responses to checkpoint inhibition in metastatic triple negative breast cancer driven by divergent myeloid phenotypes
by: Avia D. Wilkerson, et al.
Published: (2025-05-01)

Neural crest-associated gene FOXD1 induces an immunosuppressive microenvironment by regulating myeloid-derived suppressor cells in melanoma
by: Jochen Sven Utikal, et al.
Published: (2025-04-01)

Myeloid-Derived Suppressor Cells in Bladder Cancer: An Emerging Target
by: Clément Klein, et al.
Published: (2024-10-01)

Deletion of gasdermin D promotes granulocytic myeloid-derived suppressor cell differentiation by decreased release of mitochondrial DNA to promote tumor escape
by: Min Gu, et al.
Published: (2025-07-01)

MARCO expression on myeloid-derived suppressor cells is essential for their differentiation and immunosuppression
by: Sijia Liu, et al.
Published: (2025-07-01)

Myeloid-derived suppressor cells in secondary sepsis: Is there an association with lethal outcome?
by: Udovičić Ivo, et al.
Published: (2020-01-01)

Phenotypic and Functional Diversities of Myeloid-Derived Suppressor Cells in Autoimmune Diseases
by: Huijuan Ma, et al.
Published: (2018-01-01)

The predictive value of peripheral blood monocytic myeloid-derived suppressor cells for survival and immunotherapy responses in tumor patients
by: Wanying Sheng, et al.
Published: (2025-05-01)

Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients
by: Yazan S. Khaled, et al.
Published: (2014-01-01)

Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
by: Diwakar Davar, et al.
Published: (2024-07-01)

Inhibiting CMTM4 reverses the immunosuppressive function of myeloid-derived suppressor cells and augments immunotherapy response in cervical cancer
by: Bo Yin, et al.
Published: (2025-06-01)

Circulating Monocytic Myeloid-Derived Suppressor Cells Are Elevated and Associated with Poor Prognosis in Acute Myeloid Leukemia
by: Huiping Wang, et al.
Published: (2020-01-01)

Abnormal proportions and functions of myeloid-derived suppressor cells in peripheral blood of patients with diffuse large B-cell lymphoma
by: Jingru Liu, et al.
Published: (2025-04-01)

Myeloid-derived suppressor cells in axial spondyloarthritis patients with different types of therapy
by: A. Yu. Morenkova, et al.
Published: (2024-06-01)

Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations
by: Tianying Hu, et al.
Published: (2025-06-01)

Recruitment of Polymorphonuclear Myeloid-Derived Suppressor Cells During Cryptococcus neoformans Infection
by: JOYCE C. GUIMARÃES-DE-OLIVEIRA, et al.
Published: (2025-04-01)

The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity
by: Qi Zhang, et al.
Published: (2015-01-01)

Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy
by: Shuyan He, et al.
Published: (2025-01-01)

Immunometabolism signature derived from on-treatment tumor specimens predicts immune checkpoint blockade response in metastatic melanoma
by: Shuzhao Chen, et al.
Published: (2025-07-01)

Myeloid-derived suppressor cell inhibits T-cell-based defense against Klebsiella pneumoniae infection via IDO1 production.
by: Qi Xu, et al.
Published: (2025-03-01)

Myeloid-Derived Suppressor Cells Show Different Frequencies in Diabetics and Subjects with Arterial Hypertension
by: Julio C. Fernández-Ruiz, et al.
Published: (2019-01-01)

Effect of pregnancy-specific β1-glycoprotein on myeloid-derived suppressor cell differentiation
by: V. P. Timganova, et al.
Published: (2023-06-01)

Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation
by: Irina Lyadova Vladimirovna, et al.
Published: (2016-01-01)

Galectin‐9 and myeloid‐derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia
by: Xierenguli Alimu, et al.
Published: (2023-05-01)

Targeting Myeloid-Derived Suppressor Cells via Dual-Antibody Fluorescent Nanodiamond Conjugate
by: Colin D. Angell, et al.
Published: (2024-09-01)

Correction: Efficacy of immune checkpoint inhibitors for in-transit melanoma
Published: (2020-10-01)

GuBenPeiYuan Formula Inhibits Lung Cancer Metastasis by Suppressing Myeloid-Derived Suppressor Cells and Related Immune Cells
by: Yizhao Du MD, et al.
Published: (2025-04-01)

HDAC1-3 inhibition triggers NEDD4-mediated CCR2 downregulation and attenuates immunosuppression in myeloid-derived suppressor cells
by: Zhiqi Xie, et al.
Published: (2025-02-01)